Digital drug shortage fix stalls at Ethiopia hospital doors

The gap between promise and shelf

Ethiopia has a digital platform designed to fix its chronic drug shortages. The platform exists. But a report from Addis Fortune says it struggles to reach hospital shelves. That sums up the problem in one sentence.

Drug shortages in Ethiopia are not new. The public health system relies on the Pharmaceuticals Fund and Supply Agency (PFSA) to procure and distribute medicines. Delays and stockouts are routine. A digital solution that tracks inventory and predicts demand sounds logical.

So why is it not at the hospitals? The report does not spell out the details, but the pattern is familiar. Implementation requires infrastructure: reliable power, internet, and staff trained to use the system. Many public hospitals lack all three. The platform may also require subscription fees or licensing costs that strain already-tight budgets.

What this means for investors

Here is the uncomfortable question: if a digital tool that could save lives cannot get adopted, what does that say about the market for B2B SaaS in Ethiopia's public sector?

The platform's struggle suggests the business model is flawed. Either the product does not fit the actual workflow, or the buyer (likely the government) cannot or will not pay enough to sustain the vendor. Either way, the risk is that the company behind it burns cash waiting for procurement cycles that never come.

Compare this to private-sector health supply chains in Ethiopia, where some online pharmacies have managed to scale by charging consumers directly. Public-sector digital health solutions often die on the vine because the only customer is the Ministry of Health. It pays late, or not at all.

Investors should ask three questions about any digital health platform targeting Ethiopian public hospitals. First, is there a government contract with committed funding, or is it a pilot? Pilots rarely scale. Second, who owns the data? If the platform locks hospitals into proprietary software without exportable records, that is a red flag. Third, can the platform work offline? Most hospitals outside Addis Ababa have intermittent connectivity.

The chance that a single digital platform solves Ethiopia's drug shortages is slim. More likely, it will take a mix of regulatory reform (the Ethiopian Food and Drug Authority needs to simplify import approvals), better PFSA logistics, and multiple interoperable systems. Any vendor promising a silver bullet deserves skepticism.

The blunt verdict

The report tells investors something they do not want to hear: a good idea is not enough. The hardest part of selling software to African governments is not the technology. It is the buying process, the budget constraints, and the gap between what the contract says and what the hospital actually needs.

Expect more digital health pilots in Ethiopia to follow the same arc: funded launch, modest traction, then slow fade. The winners will be those who secure multi-year donor funding or anchor themselves to private-sector demand.